CC
CDLX icon

Cannell Capital’s Cardlytics CDLX Stock Holding History

Cannell Capital’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-62,698
Closed -$16.3M – 46
2019
Q2 		$16.3M Hold
62,698
– – 4.62% 6
2019
Q1 		$10.4M Buy
62,698
+11,996
+24% +$1.95M 2.52% 15
2018
Q4 		$5.49M Buy
+50,702
New +$8.55M 1.53% 24

Other funds holding CDLX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CIP
CAS Investment Partners Westport, Connecticut $1.88B AUM 2.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return
AA
Antipodean Advisors New York $19.5M AUM 6.21% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $44.4B AUM 36.05% 1-Year Est. Return

Cannell Capital's CDLX Position: Q3 2019 in Review

Cannell Capital sold out of Cardlytics (CDLX) in Q3 2019, closing a stake of 62,698 shares — an estimated $16.3M sold.

Cannell Capital first reported a position in CDLX in Q4 2018 and held it in 3 quarters. The position peaked at $16.3M in Q2 2019. 117 funds tracked by Wall St. Rank hold CDLX as of Q3 2019.

  • Cannell Capital reported no remaining Cardlytics position as of Q3 2019 after selling out during the quarter.
  • Cannell Capital sold 62,698 Cardlytics shares in Q3 2019, an estimated $16.3M.
  • Cannell Capital first reported a position in Cardlytics in Q4 2018 and held it in 3 quarters.
  • Cannell Capital's Cardlytics position peaked at $16.3M in Q2 2019.
  • 117 funds tracked by Wall St. Rank held Cardlytics as of Q3 2019.

Based on Cannell Capital's 13F filing for Q3 2019, filed 14 Nov 2019.